73 related articles for article (PubMed ID: 21713325)
1. The inhibition effect of anti-GPIIIa49-66 antibody on megakaryocyte differentiation.
Pan R; Wang J; Nardi MA; Li Z
Thromb Haemost; 2011 Sep; 106(3):484-90. PubMed ID: 21713325
[TBL] [Abstract][Full Text] [Related]
2. Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase.
Nardi MA; Gor Y; Feinmark SJ; Xu F; Karpatkin S
Blood; 2007 Sep; 110(6):1989-96. PubMed ID: 17545506
[TBL] [Abstract][Full Text] [Related]
3. Integrin GPIIIa49-57 is the pivotal switch controlling platelet fragmentation.
Zhou Y; Jing F; Shen N; Liu M; Wang J; Hong T; Dang S; Zhang W
Platelets; 2015; 26(7):693-8. PubMed ID: 25806656
[TBL] [Abstract][Full Text] [Related]
4. The effect of decitabine on megakaryocyte maturation and platelet release.
Wang J; Yi Z; Wang S; Li Z
Thromb Haemost; 2011 Aug; 106(2):337-43. PubMed ID: 21713321
[TBL] [Abstract][Full Text] [Related]
5. Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta3 integrin.
Li Z; Nardi MA; Wu J; Pan R; Zhang W; Karpatkin S
J Biol Chem; 2008 Feb; 283(6):3224-3230. PubMed ID: 18056258
[TBL] [Abstract][Full Text] [Related]
6. Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.
Nardi M; Feinmark SJ; Hu L; Li Z; Karpatkin S
J Clin Invest; 2004 Apr; 113(7):973-80. PubMed ID: 15057303
[TBL] [Abstract][Full Text] [Related]
7. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors.
Drayer AL; Olthof SG; Vellenga E
Stem Cells; 2006 Jan; 24(1):105-14. PubMed ID: 16123382
[TBL] [Abstract][Full Text] [Related]
9. Compared effects of Mpl ligand and other cytokines on human MK differentiation.
Vitrat N; Cohen-Solal K; Norol F; Guichard J; Cramer E; Vainchenker W; Wendling F; Debili N
Stem Cells; 1998; 16 Suppl 2():37-51. PubMed ID: 11012176
[TBL] [Abstract][Full Text] [Related]
10. Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66.
Zhang W; Dang S; Wang J; Nardi MA; Zan H; Casali P; Li Z
Autoimmunity; 2010 Dec; 43(8):682-9. PubMed ID: 20828249
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
[TBL] [Abstract][Full Text] [Related]
12. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
13. Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.
Li Z; Nardi MA; Karpatkin S
Blood; 2005 Jul; 106(2):572-6. PubMed ID: 15774614
[TBL] [Abstract][Full Text] [Related]
14. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
15. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.
Erickson-Miller CL; DeLorme E; Tian SS; Hopson CB; Stark K; Giampa L; Valoret EI; Duffy KJ; Luengo JL; Rosen J; Miller SG; Dillon SB; Lamb P
Exp Hematol; 2005 Jan; 33(1):85-93. PubMed ID: 15661401
[TBL] [Abstract][Full Text] [Related]
16. [hNUDC promotes proliferation and differentiation of megakaryocytopoiesis on human CD341+ cells].
Chen YQ; Ge YC; Xu PL; Yang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):962-5. PubMed ID: 18845079
[TBL] [Abstract][Full Text] [Related]
17. [In vitro expansion of cord blood megakaryocyte progenitor].
Feng Y; Xiao ZJ; Xu SC; Lu SH; Liu B; Liu JH; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):199-204. PubMed ID: 15960266
[TBL] [Abstract][Full Text] [Related]
18. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
[TBL] [Abstract][Full Text] [Related]
19. Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa.
Miyazaki H; Inoue H; Yanagida M; Horie K; Mikayama T; Ohashi H; Nishikawa M; Suzuki T; Sudo T
Exp Hematol; 1992 Aug; 20(7):855-61. PubMed ID: 1628703
[TBL] [Abstract][Full Text] [Related]
20. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
